Sargent Investment Group’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-16,670
| Closed | -$13.5K | – | 237 |
|
2025
Q1 | $13.5K | Sell |
16,670
-7,615
| -31% | -$6.15K | ﹤0.01% | 232 |
|
2024
Q4 | $35.7K | Sell |
24,285
-18,845
| -44% | -$27.7K | 0.01% | 232 |
|
2024
Q3 | $44.9K | Hold |
43,130
| – | – | 0.01% | 210 |
|
2024
Q2 | $74.6K | Sell |
43,130
-5,570
| -11% | -$9.64K | 0.02% | 212 |
|
2024
Q1 | $116K | Buy |
48,700
+22,640
| +87% | +$54.1K | 0.03% | 192 |
|
2023
Q4 | $86.8K | Buy |
26,060
+6,368
| +32% | +$21.2K | 0.02% | 204 |
|
2023
Q3 | $73.6K | Hold |
19,692
| – | – | 0.02% | 197 |
|
2023
Q2 | $84.1K | Buy |
+19,692
| New | +$84.1K | 0.02% | 191 |
|
2023
Q1 | – | Sell |
-11,200
| Closed | -$88.7K | – | 198 |
|
2022
Q4 | $88.7K | Sell |
11,200
-3,970
| -26% | -$31.4K | 0.03% | 186 |
|
2022
Q3 | $148K | Sell |
15,170
-6,355
| -30% | -$62K | 0.05% | 173 |
|
2022
Q2 | $156K | Sell |
21,525
-5,105
| -19% | -$37K | 0.05% | 171 |
|
2022
Q1 | $344K | Sell |
26,630
-13,104
| -33% | -$169K | 0.09% | 137 |
|
2021
Q4 | $634K | Sell |
39,734
-6,806
| -15% | -$109K | 0.14% | 107 |
|
2021
Q3 | $748K | Sell |
46,540
-51,195
| -52% | -$823K | 0.18% | 95 |
|
2021
Q2 | $1.35M | Sell |
97,735
-6,748
| -6% | -$93.3K | 0.32% | 56 |
|
2021
Q1 | $1.53M | Buy |
104,483
+6,739
| +7% | +$98.4K | 0.4% | 49 |
|
2020
Q4 | $1.7M | Sell |
97,744
-8,092
| -8% | -$141K | 0.54% | 39 |
|
2020
Q3 | $1.94M | Buy |
105,836
+14,656
| +16% | +$269K | 0.71% | 31 |
|
2020
Q2 | $1.66M | Buy |
91,180
+9,505
| +12% | +$173K | 0.63% | 35 |
|
2020
Q1 | $1.33M | Buy |
81,675
+17,420
| +27% | +$283K | 0.61% | 38 |
|
2019
Q4 | $1.16M | Buy |
64,255
+22,720
| +55% | +$409K | 0.42% | 49 |
|
2019
Q3 | $841K | Buy |
41,535
+24,920
| +150% | +$505K | 0.38% | 64 |
|
2019
Q2 | $367K | Buy |
+16,615
| New | +$367K | 0.17% | 99 |
|